KalVista Pharmaceuticals (KALV) Operating Margin (QoQ) (2014 - 2025)
KalVista Pharmaceuticals (KALV) Operating Margin (QoQ) (2014 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
KalVista Pharmaceuticals |
1.44 Bn |
1.25 Bn |
56.41 Mn |
| Date | Value |
|---|
| Jul 31, 2025 |
39,675.00 |
| Apr 30, 2020 |
57,262.00 |
| Jan 31, 2020 |
-56,988.00 |
| Oct 31, 2019 |
4,692.00 |
| Jul 31, 2019 |
10,094.00 |
| Apr 30, 2019 |
-21,362.00 |
| Jan 31, 2019 |
-8,371.00 |
| Oct 31, 2018 |
10,102.00 |
| Jul 31, 2018 |
-12,717.00 |
| Apr 30, 2018 |
12,510.00 |
| Jan 31, 2018 |
34,035.00 |
| Oct 31, 2017 |
515,341.00 |
| Jul 31, 2017 |
-121,880.00 |
| Apr 30, 2017 |
-118,842.00 |
| Jan 31, 2017 |
-122,984.00 |
| Oct 31, 2016 |
-151,802.00 |
| Mar 31, 2016 |
-1.37 Mn |
| Dec 31, 2015 |
-957,143.00 |
| Sep 30, 2015 |
1.10 Mn |
| Jun 30, 2015 |
-1.09 Mn |
